Filing Details

Accession Number:
0001179110-11-012087
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-08-11 16:19:32
Reporting Period:
2011-08-10
Filing Date:
2011-08-11
Accepted Time:
2011-08-11 15:19:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1107421 Ziopharm Oncology Inc ZIOP Services-Specialty Outpatient Facilities, Nec (8093) 841475642
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1301268 Wyche Fowler 701 A Street Ne
Washington DC 20002
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $.001 Par Value Acquisiton 2011-08-10 5,000 $5.19 72,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock, $.001 Par Value Director Stock Option (right to buy) $4.31 2006-12-22 2014-12-22 15,029 15,029 Direct
Common Stock Director Stock Option (riht to buy) $5.01 2006-04-26 2016-04-26 15,000 15,000 Direct
Common Stock Director Stock Option (right to buy) $6.49 2006-12-13 2016-12-13 15,000 15,000 Direct
Common Stock Stock Option (right to buy) $4.85 2010-06-18 2017-06-18 15,000 15,000 Direct
Common Stock Stock Option (right to buy) $2.73 2017-12-12 20,000 20,000 Direct
Common Stock Stock Option (right to buy) $0.70 2019-05-13 15,000 15,000 Direct
Common Stock, $.001 Par Value Stock Option (right to buy) $2.85 2019-12-31 7,500 7,500 Direct
Common Stock, $.001 Par Value Stock Option (right to buy) $5.09 2011-03-31 2020-03-31 15,000 15,000 Direct
Common Stock Stock Option (right to buy) $4.77 2020-12-31 30,000 30,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2014-12-22 15,029 15,029 Direct
2016-04-26 15,000 15,000 Direct
2016-12-13 15,000 15,000 Direct
2017-06-18 15,000 15,000 Direct
2017-12-12 20,000 20,000 Direct
2019-05-13 15,000 15,000 Direct
2019-12-31 7,500 7,500 Direct
2020-03-31 15,000 15,000 Direct
2020-12-31 30,000 30,000 Direct
Footnotes
  1. The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.15 to $5.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth.
  2. Includes grants of restricted stock with restrictions that lapsed as to 3,750 shares on December 31, 2010 and 15,000 shares on March 31, 2011 and restrictions that will lapse as to 3,750 shares on December 31, 2011.
  3. 6,667 shares vest on each of 12/12/08 and 12/12/09; 6,666 shares vest on 12/12/10.
  4. 5,000 shares vest on each of 12/31/09, 6/30/2010 and 12/31/2010.
  5. 3,750 shares vest on each of 12/31/2010 and 12/31/2011.
  6. 10,000 shares vest on each of 12/31/2011, 12/31/2012 and 12/31/2013.